S4 Ep11: How to Improve Perception Hurdles to Biosimilar Adoption - a podcast by Not So Different: a Podcast from The Center for Biosimilars

In March 2021, the National Comprehensive Cancer Network’s (NCCN) Oncology Research Program, in partnership with Pfizer, announced that 10 research projects have been chosen to receive funding to focus on innovative ways to improve biosimilar adoption in the oncology space.

For this 3-part series of Not So Different, The Center for Biosimilars® has chosen 3 projects that relate to improving perception of biosimilars, choice of biosimilars, and payer preferences for biosimilars.

In this first part, we spoke with Claire Saxton, vice president of education at Cancer Support Community, a worldwide patient and family advocacy organization that provides financial support and navigation services. Saxton discussed how her project titled “Frankly Speaking About Cancer: Biosimilars—Researching Oncology Patient and Caregiver Perceptions” will help address the current perception issues surrounding biosimilars.

Further episodes of Not So Different: a Podcast from The Center for Biosimilars

Further podcasts by Not So Different: a Podcast from The Center for Biosimilars

Website of Not So Different: a Podcast from The Center for Biosimilars